C Bellanné-Chantelot, C Carette, JP Riveline, R Valéro … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Missense mutations prevailed in the dimerization and DNA-binding domains
(74%), while truncating mutations were predominant in the transactivation domain (62%). The
majority (83%) of the mutations were located in exons 1- 6, thus affecting the three ... Cited by 15 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] D Martin, C Bellanné-Chantelot, I Deschamps, P … - Diabetes Care, 2008 - Am Diabetes Assoc Page 1. Long-term follow-up of MODY2 subjects Long-term follow-up of OGTT-derived glucose
tolerance, insulin secretion and insulin sensitivity indices in subjects with glucokinase mutations
(MODY2) Delphine Martin, MD 1 , Christine Bellanné-Chantelot, PhD ... Cited by 3 - Related articles - All 3 versions
[CITATION] AT Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of …
S Ellard, K Thomas, EL Edghill, M Owens, L Ambye, J … - Diabetologia, 2007 - Springer Page 1. SHORT COMMUNICATION Partial and whole gene deletion mutations of the GCK
and HNF1A genes in maturity-onset diabetes of the young S. Ellard & K. Thomas & EL Edghill
& M. Owens & L. Ambye & J. Cropper & J. Little & M. Strachan & ... Cited by 19 - Related articles - BL Direct - All 2 versions
[CITATION] Prevalence of MODY mutations in Brazilian families with autosomal dominant early …
GK Furuzawa, FMA Giuffrida, CSV Oliveira, AR … - Diabetes Research and …, 2008 - Elsevier Maturity-onset diabetes of the young (MODY) accounts for 2–5% of all cases of diabetes. MODY2
and MODY3, caused, respectively, by mutations in glucokinase (GCK) and hepatocyte nuclear
factor-1alpha (HNF1A), are the most common causes of MODY in all Caucasian ... Cited by 8 - Related articles - All 17 versions
S Ellard, K Colclough - Human mutation, 2006 - interscience.wiley.com Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes mellitus characterized
by autosomal dominant inheritance, early age of onset (often <25 years of age), and pancreatic
-cell dysfunction. MODY is both clinically and genetically heterogeneous, with six different ... Cited by 33 - Related articles - BL Direct - All 4 versions
- ►endojournals.org A Johansen, J Ek, HB Mortensen, O Pedersen, … - Journal of Clinical …, 2005 - Endocrine Soc Aims/Hypothesis: Maturity-onset diabetes of the young (MODY) is a genetically heterogeneous
monogenic form of diabetes characterized by an autosomal dominant inheritance, an early clinical
onset, and a primary defect in ß-cell function. The aims of the present study were to ... Cited by 22 - Related articles - BL Direct - All 5 versions
A Molven, M Ringdal, AM Nordbø, H Ræder, J Støy, … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Among the MODY patients, we identified the INS mutation c.137G>A (R46Q) in a
proband, his diabetic father, and a paternal aunt. They were diagnosed with diabetes at 20,
18, and 17 years of age, respectively, and are treated with small doses of insulin or diet ... Cited by 19 - Related articles - BL Direct - All 4 versions
